Corteva Inc. (CTVA) shares fell sharply on Oct. 1 after completing the long-planned separation of its seed and advanced genetics division into Vylor Inc. (VYLR), which debuted on the New York Stock Exchange. The 84% drop to $12.57 from Wednesday’s close of $77.65 was not a loss of value, but a mechanical transfer of equity: shareholders of record as of Sept. 24 received one VYLR share for each CTVA share held.
Vylor closed its first session at $68.26, bringing combined CTVA+VYLR value to roughly $81, a modest gain from Wednesday’s level. The split shifted most of the old company’s market capitalization to Vylor, which generated about $10 billion in 2025 sales and $3 billion in EBITDA, while Corteva’s retained crop protection business posted $7.5 billion in sales and $1.4 billion in EBITDA.
The transaction cleared a late legal hurdle on Sept. 30, when a U.S. District Court denied California’s motion for a temporary restraining order. The state had argued the spinoff was designed to shield seed assets from PFAS-related environmental liabilities, but the court noted California waited until days before closing despite knowing about the plan for nearly a year.
Index changes follow the spinoff. S&P Dow Jones Indices said Vylor will replace Corteva in the S&P 500 on Oct. 6, with Vylor classified in consumer staples and Corteva moving to the S&P MidCap 400. Twilio will also join the S&P 500, taking the spot vacated by Warner Bros. Discovery as its acquisition by Paramount Skydance nears completion.
Wall Street analysts maintain a consensus Overweight rating on CTVA, highlighting an $11 billion innovation pipeline and a dividend yield near 5.92%. Oppenheimer’s Kristen Owen called Corteva cheap below $12, at roughly six to seven times future EBITDA, versus Vylor’s first-day multiple closer to 15 times EBITDA.
